Brief: Telomir Pharmaceuticals Confirms Lifespan Restoration And Normalization Of Accelerated Aging In Preclinical Model Of Progeria
07/01/2025 13:19
Jan 7 (Reuters) - Telomir Pharmaceuticals Inc TELO.O :
* TELOMIR PHARMACEUTICALS: CONFIRMS LIFESPAN RESTORATION AND
NORMALIZATION OF ACCELERATED AGING IN PRECLINICAL MODEL OF
PROGERIA
Source text: ID:n0001493152-25-001112
Further company coverage: TELO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Telomir Pharmaceuticals
See all newsBrief: Telomir Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing
Brief: Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality In Human Triple-Negative Breast Cancer Models
Brief: Telomir Pharmaceuticals Telomir-1 Significantly Reduced Tumor Growth And Metastases
Brief: Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer’S “Kill-And-Clean” Defense Systems In An Aggressive Prostate Cancer Model
U.S. STOCKS ON THE MOVE-InterDigital, Scholar Rock, Live Nation